Outlook Therapeutics, Inc. · NASDAQ:OTLK
Tang Capital Management LLC reported a 5.60% stake in Outlook Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Tang Capital Management LLC reported a 5.60% stake in Outlook Therapeutics, Inc., 1,900,000 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 5.60%
- Shares
- 1,900,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 5.60% | 1,900,000 |
| KEVIN TANG | 5.60% | 1,900,000 |
| TANG CAPITAL PARTNERS, LP | 4.90% | 1,662,182 |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.30% | 102,818 |
| TANG CAPITAL PARTNERS III, INC | 0.40% | 135,000 |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 |
Source
Related
- Outlook Therapeutics, Inc.
- Tang Capital Management LLC
- Outlook Therapeutics, Inc. shareholders
- Schedule 13G/A · Tang Capital Management LLC · Aug 14, 2025
- Schedule 13G · Empery Asset Management, LP · Oct 13, 2026
- Schedule 13G · CVI Investments, Inc. · Aug 19, 2026
- Form 4 · Jahr Robert Charles · Aug 14, 2026
- Form 4 · Kenyon Lawrence A · Aug 14, 2026
- Form 4 · Sukhtian Ghiath M. · Aug 14, 2026